Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SNBR - US83125X1037 - Common Stock

5.565 USD
+0.47 (+9.12%)
Last: 12/1/2025, 3:03:09 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SNBR. SNBR was compared to 122 industry peers in the Specialty Retail industry. SNBR has a bad profitability rating. Also its financial health evaluation is rather negative. SNBR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
In the past year SNBR has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
Of the past 5 years SNBR 4 years had a positive operating cash flow.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With a Return On Assets value of -10.42%, SNBR is not doing good in the industry: 73.77% of the companies in the same industry are doing better.
SNBR has a Return On Invested Capital (3.59%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for SNBR is below the industry average of 11.71%.
The last Return On Invested Capital (3.59%) for SNBR is well below the 3 year average (7.69%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin (1.35%) which is in line with its industry peers.
SNBR's Operating Margin has declined in the last couple of years.
The Gross Margin of SNBR (60.05%) is better than 90.16% of its industry peers.
In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SNBR has been increased compared to 1 year ago.
SNBR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNBR has a worse debt to assets ratio.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of -0.14. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SNBR (-0.14) is worse than 77.87% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.14
ROIC/WACC0.44
WACC8.15%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SNBR (0.19) is worse than 97.54% of its industry peers.
A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
SNBR has a worse Quick ratio (0.09) than 95.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

SNBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.40%.
SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.95%.
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%

3.2 Future

SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.93% yearly.
Based on estimates for the next years, SNBR will show a decrease in Revenue. The Revenue will decrease by -3.38% on average per year.
EPS Next Y-4.64%
EPS Next 2Y58.79%
EPS Next 3Y42.15%
EPS Next 5Y34.93%
Revenue Next Year-14.98%
Revenue Next 2Y-7.32%
Revenue Next 3Y-3.72%
Revenue Next 5Y-3.38%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
SNBR is valuated reasonably with a Price/Forward Earnings ratio of 11.86.
Based on the Price/Forward Earnings ratio, SNBR is valued cheaply inside the industry as 80.33% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.56. SNBR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 11.86
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

96.72% of the companies in the same industry are more expensive than SNBR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.47
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as SNBR's earnings are expected to grow with 42.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.79%
EPS Next 3Y42.15%

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SLEEP NUMBER CORP

NASDAQ:SNBR (12/1/2025, 3:03:09 PM)

5.565

+0.47 (+9.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners82.45%
Inst Owner Change9.11%
Ins Owners6.8%
Ins Owner Change-0.06%
Market Cap126.83M
Revenue(TTM)1.44B
Net Income(TTM)-78.11M
Analysts48.89
Price Target5.61 (0.81%)
Short Float %42.02%
Short Ratio12.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)-26.67%
PT rev (3m)-26.67%
EPS NQ rev (1m)-303.9%
EPS NQ rev (3m)-370.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.74%
Revenue NQ rev (1m)-5.44%
Revenue NQ rev (3m)-7.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.86
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.47
EPS(TTM)-3.41
EYN/A
EPS(NY)0.47
Fwd EY8.43%
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.14
F-Score4
WACC8.15%
ROIC/WACC0.44
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
EPS Next Y-4.64%
EPS Next 2Y58.79%
EPS Next 3Y42.15%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%
Revenue Next Year-14.98%
Revenue Next 2Y-7.32%
Revenue Next 3Y-3.72%
Revenue Next 5Y-3.38%
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year285.6%
EBIT Next 3Y61.07%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 2 / 10 to SNBR.


Can you provide the valuation status for SLEEP NUMBER CORP?

ChartMill assigns a valuation rating of 4 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Fairly Valued.


What is the profitability of SNBR stock?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


How financially healthy is SLEEP NUMBER CORP?

The financial health rating of SLEEP NUMBER CORP (SNBR) is 0 / 10.